The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data

BACKGROUND: The majority of Plasmodium falciparum malaria cases in Africa are treated with the artemisinin combination therapies artemether-lumefantrine (AL) and artesunate-amodiaquine (AS-AQ), with amodiaquine being also widely used as part of seasonal malaria chemoprevention programs combined with...

Descripción completa

Detalles Bibliográficos
Autores principales: Bretscher, Michael T., Dahal, Prabin, Griffin, Jamie, Stepniewska, Kasia, Bassat, Quique, Baudin, Elisabeth, D’Alessandro, Umberto, Djimde, Abdoulaye A., Dorsey, Grant, Espié, Emmanuelle, Fofana, Bakary, González, Raquel, Juma, Elizabeth, Karema, Corine, Lasry, Estrella, Lell, Bertrand, Lima, Nines, Menéndez, Clara, Mombo-Ngoma, Ghyslain, Moreira, Clarissa, Nikiema, Frederic, Ouédraogo, Jean B., Staedke, Sarah G., Tinto, Halidou, Valea, Innocent, Yeka, Adoke, Ghani, Azra C., Guerin, Philippe J., Okell, Lucy C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043031/
https://www.ncbi.nlm.nih.gov/pubmed/32098634
http://dx.doi.org/10.1186/s12916-020-1494-3

Ejemplares similares

Ejemplares similares